What is Coronary Artery Disease?
Coronary artery disease (CAD) is a condition where the major blood vessels that supply the heart muscle become narrowed or blocked due to plaque buildup, reducing blood flow to the heart. It is the most common type of heart disease and the leading cause of death worldwide, affecting millions of people across all demographics. CAD typically develops gradually over decades, often remaining silent until blood flow is significantly restricted. While it can affect anyone, it becomes more common with age and is influenced by lifestyle factors, genetics, and other medical conditions.
Key statistics
| Statistic | Value |
|---|---|
| Global prevalence | 126 million people (1.72% of global population) |
| Annual deaths | 9.14 million globally |
| Age of onset | Typically begins in 40s-50s, but can start earlier |
| Gender difference | Men develop CAD 7-10 years earlier than women on average |
Symptoms
Common symptoms: Chest pain or discomfort (angina), shortness of breath, fatigue, heart palpitations, weakness, nausea, sweating.
CAD symptoms often develop gradually and may initially occur only during physical exertion or emotional stress. Chest pain or angina is the most characteristic symptom, typically described as pressure, squeezing, or burning sensation in the center of the chest that may radiate to the arms, neck, jaw, or back. Shortness of breath may occur during activities that were previously manageable. Some people experience unusual fatigue, particularly women, who may have less typical symptoms. Silent ischemia can occur without noticeable symptoms, particularly in people with diabetes. Serious symptoms indicating a heart attack include severe chest pain lasting more than a few minutes, pain spreading to other areas, cold sweats, nausea, and lightheadedness.
Causes and risk factors
CAD is primarily caused by atherosclerosis, a process where fatty deposits (plaques) build up in the coronary artery walls over time. These plaques contain cholesterol, cellular waste, calcium, and fibrin, gradually narrowing the arteries and reducing blood flow to the heart muscle.
Major risk factors include: High blood pressure, high cholesterol levels, diabetes, smoking, obesity, physical inactivity, unhealthy diet, and family history of heart disease. Age and gender play significant roles, with men over 45 and women over 55 at increased risk. Genetic factors contribute significantly, with familial hypercholesterolemia and other inherited conditions affecting lipid metabolism. Environmental factors such as air pollution, chronic stress, and excessive alcohol consumption also contribute to CAD development.
Prevention
CAD is largely preventable through lifestyle modifications and management of risk factors. Dietary changes including adopting a Mediterranean-style diet rich in fruits, vegetables, whole grains, and healthy fats can significantly reduce risk. Regular physical activity of at least 150 minutes of moderate-intensity exercise weekly strengthens the heart and improves circulation. Smoking cessation is crucial, as smoking damages blood vessels and accelerates atherosclerosis.
Medical management includes controlling blood pressure (target Screening recommendations include regular blood pressure checks starting at age 18, cholesterol screening every 4-6 years for adults over 20, and diabetes screening every 3 years starting at age 45. Medications such as statins may be recommended for high-risk individuals even without elevated cholesterol levels.
Complications
Without proper treatment, CAD can lead to serious complications. Heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is completely blocked, causing tissue death. Heart failure may develop when the heart muscle becomes weakened and cannot pump blood effectively throughout the body. Arrhythmias or abnormal heart rhythms can result from damaged heart tissue, potentially leading to sudden cardiac death.
Chronic complications include progressive heart muscle damage, reduced exercise capacity, and decreased quality of life. Stroke risk increases due to similar atherosclerotic processes affecting brain arteries. Long-term CAD may also lead to peripheral artery disease, kidney disease, and cognitive decline due to reduced blood flow to various organs.
Diagnosis
CAD diagnosis involves multiple approaches combining clinical assessment, laboratory tests, and imaging studies. Clinical evaluation includes detailed medical history, physical examination, and assessment of symptoms and risk factors.
Initial tests include electrocardiogram (ECG) to detect heart rhythm abnormalities and signs of previous heart attacks, and blood tests measuring cholesterol levels, blood sugar, and cardiac enzymes. Stress testing evaluates heart function during physical or pharmacologic stress, revealing areas of inadequate blood flow.
Advanced imaging includes echocardiography to assess heart muscle function, coronary angiography (the gold standard) to visualize coronary artery blockages, and coronary CT angiography as a less invasive alternative. Nuclear stress tests and cardiac MRI provide detailed information about blood flow and heart muscle viability.
Treatment
CAD treatment focuses on improving blood flow, reducing symptoms, and preventing complications through medications, procedures, and lifestyle modifications.
Medications include aspirin for blood clot prevention, atorvastatin and other statins for cholesterol management, metoprolol and other beta-blockers to reduce heart workload, and lisinopril or other ACE inhibitors for blood pressure control. Nitroglycerin provides rapid relief for angina episodes.
Interventional procedures include percutaneous coronary intervention (PCI) with stent placement to open blocked arteries, and coronary artery bypass grafting (CABG) surgery for severe, multi-vessel disease. Newer therapies include drug-eluting stents, PCSK9 inhibitors for cholesterol management, and enhanced external counterpulsation for refractory angina.
Prognosis
The prognosis for CAD varies significantly based on disease severity, treatment response, and adherence to lifestyle modifications. With appropriate treatment, many people with CAD live normal lifespans and maintain good quality of life. Early detection and intervention dramatically improve outcomes, with 5-year survival rates exceeding 95% for stable CAD.
Factors affecting prognosis include extent of coronary artery involvement, left ventricular function, presence of diabetes, age at diagnosis, and adherence to medications and lifestyle changes. Without treatment, CAD typically progresses, leading to increased risk of heart attack, heart failure, and death. However, aggressive risk factor modification can slow or even reverse atherosclerotic progression in some cases.
Quality of life
Living with CAD requires ongoing lifestyle adjustments and medical management to maintain optimal health and prevent progression. Dietary modifications should emphasize heart-healthy eating patterns, limiting saturated fats, trans fats, and sodium while increasing fiber-rich foods and omega-3 fatty acids.
Exercise programming should be individualized, often beginning with cardiac rehabilitation programs that provide supervised exercise training and education. Regular physical activity improves cardiovascular fitness, reduces symptoms, and enhances overall well-being. Stress management through relaxation techniques, meditation, or counseling helps reduce cardiovascular risk and improve mental health.
Medication adherence is crucial for optimal outcomes, requiring regular follow-up with healthcare providers to monitor effectiveness and adjust treatments. Social support from family, friends, and support groups provides encouragement and practical assistance with lifestyle changes. Many people successfully return to work and recreational activities with appropriate modifications and medical management.
Pregnancy and fertility
CAD during pregnancy is relatively uncommon but requires specialized management due to increased cardiovascular demands. Pregnancy effects include increased blood volume, heart rate, and cardiac output, which may exacerbate symptoms in women with existing CAD.
Medication considerations during pregnancy require careful evaluation, as some cardiac medications may not be safe for fetal development. Aspirin in low doses is generally considered safe, while ACE inhibitors and some statins should typically be avoided. Delivery planning may require specialized care with cardio-obstetric teams to manage labor and delivery safely.
Preconception counseling is essential for women with known CAD to optimize health status and medication regimens before pregnancy. Fertility is generally not directly affected by CAD, though some medications may have implications for reproductive health.
Children
CAD in children is extremely rare and typically associated with genetic conditions, congenital heart disease, or severe risk factors. Kawasaki disease can cause coronary artery abnormalities in children, requiring long-term monitoring and management.
Familial hypercholesterolemia affects approximately 1 in 500 children and significantly increases CAD risk if untreated. Prevention focus in pediatrics emphasizes establishing healthy lifestyle habits, including proper nutrition, regular physical activity, and avoiding tobacco exposure. Screening recommendations for children include cholesterol testing in those with family history of early heart disease or genetic conditions affecting lipid metabolism.
When to see a doctor
Seek immediate emergency care for chest pain lasting more than a few minutes, severe shortness of breath, chest pain with sweating or nausea, or symptoms suggesting heart attack. Call emergency services rather than driving to the hospital.
Schedule routine medical evaluation for new onset chest discomfort with exertion, unexplained shortness of breath, unusual fatigue, or palpitations. Regular follow-up is essential for people with known risk factors, including annual check-ups for blood pressure, cholesterol monitoring every 4-6 years, and diabetes screening as recommended. Urgent but non-emergency care may be needed for worsening angina patterns, increased medication requirements, or new symptoms in people with known CAD.
Regional context
The Caucasus region shows significant cardiovascular disease burden, with CAD being a leading cause of mortality in Georgia, Armenia, and Azerbaijan. Regional risk factors include high rates of smoking, traditional diets high in saturated fats, and limited access to preventive care in rural areas. Healthcare infrastructure varies across the region, with urban centers generally having better access to cardiac catheterization and surgical facilities. GMJ welcomes contributions from regional researchers to build the evidence base for coronary artery disease prevention and management strategies specific to Caucasus populations.
Research and clinical trials
Current CAD research focuses on novel therapeutic targets, personalized medicine approaches, and innovative prevention strategies. Emerging treatments include gene therapy, stem cell therapy, and nanotechnology-based drug delivery systems. PCSK9 inhibitors represent a major advancement in cholesterol management for high-risk patients.
Prevention research explores genetic risk scoring, inflammatory biomarkers, and digital health interventions for lifestyle modification. Clinical trials are investigating new antiplatelet agents, novel stent technologies, and combination therapies for optimal outcomes. Patients interested in clinical trials can search ClinicalTrials.gov for ongoing studies relevant to their condition and treatment needs.
Frequently asked questions
Can coronary artery disease be reversed?
While established plaque cannot be completely eliminated, aggressive lifestyle changes and medications can stabilize plaques, improve blood flow, and potentially slow or halt disease progression. Some studies suggest modest plaque regression is possible with intensive treatment.
How long can someone live with coronary artery disease?
With proper treatment and lifestyle modifications, many people with CAD live normal lifespans. The key is early detection, appropriate medical management, and adherence to preventive measures.
Is coronary artery disease hereditary?
Genetics play a significant role in CAD risk, with family history being an important risk factor. However, lifestyle factors often have greater impact than genetics alone, and CAD is largely preventable regardless of genetic predisposition.
What foods should be avoided with coronary artery disease?
Limit saturated fats, trans fats, excessive sodium, refined sugars, and processed foods. Focus on heart-healthy options like fruits, vegetables, whole grains, lean proteins, and healthy fats from sources like olive oil and nuts.
Can stress cause coronary artery disease?
Chronic stress contributes to CAD development through multiple mechanisms including elevated blood pressure, increased inflammation, and unhealthy coping behaviors like smoking or overeating. Stress management is an important component of CAD prevention and treatment.
Support and resources
International organizations: American Heart Association (heart.org), European Society of Cardiology (escardio.org), World Heart Federation (world-heart-federation.org), and British Heart Foundation (bhf.org.uk) provide comprehensive information and support resources.
Patient support groups: Local cardiac rehabilitation programs often include support groups, and online communities provide peer connections and shared experiences. Many hospitals offer educational programs and support services for people with CAD and their families.
Related conditions
Peripheral artery disease involves atherosclerosis affecting arteries outside the heart, commonly in legs. Carotid artery disease affects neck arteries supplying the brain, increasing stroke risk. Heart failure may develop as a complication of CAD when heart muscle becomes weakened. Atrial fibrillation is an irregular heart rhythm often associated with CAD. Stroke shares many risk factors with CAD and may occur due to similar atherosclerotic processes affecting brain blood vessels.
Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, relevant EULAR/ACR/WHO guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.
Cite this page
GMJ News Desk. “Coronary Artery Disease.” GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/condition/coronary-artery-disease/
Licensed under CC BY 4.0. Free to share with attribution to GMJ News.Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.
Was this article helpful?